• Life sciences, with a focus on nutraceuticals
• Longevity
• Specialized care including eldercare, mental illness and end-of-life care
• Emerging market healthcare solutions

•  We prioritize long-term capital growth over annualized return
•  We look at value creation from the perspective of business builders more than investors. Where we see a market trend or theme that warrants investment, we are happy to build the business ourselves if we cannot find the right company to support
•  We do not follow traditional venture capital performance benchmarks and insist that all of our projects create value across three dimensions: financial, experiential and benefit to humankind

Whilst our projects must benefit humankind, we are not interested in well-intentioned projects that are not financially rewarding or sustainable. But we also reject the notion that there is a fundamental conflict between these outcomes – that if a project adds value to society, there has to be some sort of financial trade-off. In fact, partly because of the overall human care theme of our mandate, we see opportunities to “trade-on”.